Navigation Links
Somanetics Announces Share Repurchase Program Increased By $15 Million

TROY, Mich., July 1 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) announced today that its Board of Directors has authorized the Company to repurchase up to an additional $15 million of its common shares (for a total of $45 million of its common shares). Purchases may be made from time to time in the open market or in privately negotiated transactions. The prices, timing and amount of, and purposes for, any purchases will be determined by the Company's Chief Executive Officer, Chief Financial Officer or Chief Administrative Officer. From April 3, 2008, the date its initial share repurchase program commenced, through June 30, 2008, Somanetics has spent approximately $27.7 million (including commissions) to purchase 1,631,329 shares at an average purchase price of $16.97 per share. As of June 30, 2008 Somanetics had 12,014,124 shares outstanding. The Company expects to fund its repurchase program with existing cash and cash equivalents on hand.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit .

SOURCE Somanetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling
2. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
3. Somanetics Announces Share Repurchase Program Increased by $15 Million
4. Somanetics Announces Share Repurchase Program
5. Somanetics Reports Financial Results for the First Quarter of Fiscal 2008
6. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
7. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
8. Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)
11. ABIM Foundation Announces New Focus and Governance
Post Your Comments:
(Date:11/30/2015)... VA (PRWEB) , ... November 30, 2015 , ... ... Research Foundation (Meso Foundation) released information for caregivers and held two webinars on ... are available on demand free of charge at . , With ...
(Date:11/30/2015)... Irving, TX (PRWEB) , ... November 30, 2015 ... ... for plastic surgery and dermatology, is proud to announce that its ThermiRFR temperature ... Europe. , ThermiRF is an innovative multi-application radiofrequency platform which uses temperature as ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Museum of ... ushering in a new era of publicly accessible automated technology. Now, by popular ... to offer guests an up-close look at the shuttle at MOSI’s main entrance. ...
(Date:11/30/2015)... ... November 30, 2015 , ... On Saturday, October 24th, 2015, at ... an annual fundraising event, a 5K walk known as “Making Strides Against Breast Cancer”. ... abuse which is also located in Battle Creek, joined in for this campaign that ...
(Date:11/30/2015)... ... 2015 , ... During the week of Thanksgiving, the Mesothelioma ... its research, education, support, and advocacy efforts. The campaign is held every year-end ... Applied Research Foundation, which also goes by Meso Foundation, holds the highest ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  QT Vascular Ltd., ... and together with its subsidiaries, TriReme Medical LLC and ... company engaged in the design, assembly and distribution of ... vascular disease, is pleased to announce that a three-judge ... Court of Appeals for the Federal Circuit ("Federal Circuit") ...
(Date:11/30/2015)... Nov. 30, 2015  DURECT Corporation (Nasdaq: ... Matt Hogan , Chief Financial Officer, will ... on Tuesday, December 8 at 2:45 pm ... at the Westin Grand Central Hotel in ... for one-on-one meetings at this conference; interested ...
(Date:11/30/2015)... DUBLIN , Nov. 30, 2015 ... addition of the "Orphan Drugs Market 2015-2019" ... ) has announced the addition of the ... their offering. --> Research and Markets ... the "Orphan Drugs Market 2015-2019" report ...
Breaking Medicine Technology: